You are here

drug pricing

ICER: Unsubstantiated drug price increases cost US $1.67B in 2020, but overall net increases lower than years past

ICER: Unsubstantiated drug price increases cost US $1.67B in 2020, but overall net increases lower than years past

Endpoints

Flag link:

How Nancy Pelosi almost killed drug pricing reform — a gamble that expanded Democrats’ final deal

How Nancy Pelosi almost killed drug pricing reform — a gamble that expanded Democrats’ final deal

Stat

Flag link:

Takeda launches value-based pricing program for lung cancer med Alunbrig, promises more deals to come

Takeda launches value-based pricing program for lung cancer med Alunbrig, promises more deals to come

Fierce Pharma

value-based pricing

Flag link:

Democrats' drug pricing deal is 'not a bad outcome' for pharma, analysts write

Democrats' drug pricing deal is 'not a bad outcome' for pharma, analysts write

Fierce Pharma

Flag link:

Judge rules HHS' letter enforcing 340B discounts was 'arbitrary'

Judge rules HHS' letter enforcing 340B discounts was 'arbitrary'

Beckers Hospital Review

United Therapeutics

Flag link:

Dems close in on Medicare prescription drug negotiation compromise

Dems close in on Medicare prescription drug negotiation compromise

Politico

Flag link:

Pelosi working to gather support for last-minute, last-ditch drug pricing policy

Pelosi working to gather support for last-minute, last-ditch drug pricing policy

Stat

Flag link:

White House kills off major drug pricing reforms as Democrats fail to coalesce around Medicare negotiation plan

White House kills off major drug pricing reforms as Democrats fail to coalesce around Medicare negotiation plan

Endpoints

Flag link:

With D.C. drug pricing negotiations still up in the air, the 'endgame' could still 'have a bite,' analyst says

With D.C. drug pricing negotiations still up in the air, the 'endgame' could still 'have a bite,' analyst says

Fierce Pharma

Flag link:

For the first time, WHO committee recommends action on high-priced essential medicines

For the first time, WHO committee recommends action on high-priced essential medicines

Stat

essential medicines

Flag link:

U.S. House panel approves fourth bill aimed at drug prices

U.S. House panel approves fourth bill aimed at drug prices

NASDAQ

Flag link:

Eli Lilly to reduce list price of Insulin Lispro injection by an additional 40% from Jan. 1, restoring it to 2008 levels

Eli Lilly to reduce list price of Insulin Lispro injection by an additional 40% from Jan. 1, restoring it to 2008 levels

Marketwatch

Flag link:

Pfizer CEO Bourla asks employees to join the scrum for D.C. drug-pricing fight

Pfizer CEO Bourla asks employees to join the scrum for D.C. drug-pricing fight

Fierce Pharma

Flag link:

CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington's intensifying drug-pricing push

CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington's intensifying drug-pricing push

Fierce Pharma

Bristol Myers Squibb

Flag link:

Moderate Democrats sink Pelosi’s aggressive drug pricing bill in key committee vote

Moderate Democrats sink Pelosi’s aggressive drug pricing bill in key committee vote

Stat

Flag link:

House moderates rebel against Pelosi drug pricing plan, leaving bill’s fate uncertain

House moderates rebel against Pelosi drug pricing plan, leaving bill’s fate uncertain

Stat

Flag link:

Novo Nordisk, Roche see outsized threats from U.S. drug pricing talks: analysts

Novo Nordisk, Roche see outsized threats from U.S. drug pricing talks: analysts

Fierce Pharma

Flag link:

Martin Shkreli to go toe-to-toe with new FTC chair over Daraprim price spikes

Martin Shkreli to go toe-to-toe with new FTC chair over Daraprim price spikes

Endpoints

Flag link:

New Biden plan to lower drug prices drawn from familiar Democratic playbook

New Biden plan to lower drug prices drawn from familiar Democratic playbook

Stat

Flag link:

Merck, Amgen adopt double-digit price hikes in test to Big Pharma's unofficial annual limits: analyst

Merck, Amgen adopt double-digit price hikes in test to Big Pharma's unofficial annual limits: analyst

Fierce Pharma

Flag link:

Pages